NO891713L - Monoklonale antistoffer til vevplasminogenaktivator (t-pa) - Google Patents

Monoklonale antistoffer til vevplasminogenaktivator (t-pa)

Info

Publication number
NO891713L
NO891713L NO89891713A NO891713A NO891713L NO 891713 L NO891713 L NO 891713L NO 89891713 A NO89891713 A NO 89891713A NO 891713 A NO891713 A NO 891713A NO 891713 L NO891713 L NO 891713L
Authority
NO
Norway
Prior art keywords
binding
monoclonal antibody
mab
activity
antibodies
Prior art date
Application number
NO89891713A
Other languages
English (en)
Norwegian (no)
Other versions
NO891713D0 (no
Inventor
Thomas Michael Reilly
Andrew Tak-Chau Chiu
Robert Madara Knabb
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of NO891713D0 publication Critical patent/NO891713D0/no
Publication of NO891713L publication Critical patent/NO891713L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO89891713A 1988-04-26 1989-04-25 Monoklonale antistoffer til vevplasminogenaktivator (t-pa) NO891713L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/186,277 US5225540A (en) 1988-04-26 1988-04-26 Monoclonal antibodies to tissue plasminogen activator (t-pa) which prolong its functional half-life

Publications (2)

Publication Number Publication Date
NO891713D0 NO891713D0 (no) 1989-04-25
NO891713L true NO891713L (no) 1989-10-27

Family

ID=22684316

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89891713A NO891713L (no) 1988-04-26 1989-04-25 Monoklonale antistoffer til vevplasminogenaktivator (t-pa)

Country Status (11)

Country Link
US (1) US5225540A (da)
EP (1) EP0339505A3 (da)
JP (1) JPH0213395A (da)
KR (1) KR900015759A (da)
AU (1) AU3332389A (da)
DK (1) DK166489A (da)
FI (1) FI891956A7 (da)
IL (1) IL90054A0 (da)
NO (1) NO891713L (da)
PT (1) PT90364A (da)
ZA (1) ZA893088B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04143992A (ja) * 1990-10-04 1992-05-18 Nec Corp 画像メモリのアドレス発生回路
ATE155816T1 (de) 1992-06-03 1997-08-15 Genentech Inc Varianten des gewebeplasminogenaktivators mit verbesserter therapeutischer wirkung
US9321832B2 (en) 2002-06-28 2016-04-26 Domantis Limited Ligand
EP2371390A3 (en) * 2004-10-08 2013-03-13 Domantis Limited Antagonists and methods of use therefor
KR100600039B1 (ko) * 2005-08-19 2006-07-13 최병만 시각장애인용 유도 블록
US10160813B2 (en) * 2013-01-22 2018-12-25 University Of Tennessee Research Foundation Tissue plasminogen activator antibodies and methods of use
CN114686442B (zh) * 2020-12-31 2023-11-07 广州万孚生物技术股份有限公司 一种杂交瘤细胞株及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3222084A1 (de) * 1982-06-11 1983-12-15 Bayer Ag, 5090 Leverkusen Monoklonale antikoerper
GB2148299B (en) * 1983-09-01 1988-01-06 Hybritech Inc Antibody compositions of therapeutic agents having an extended serum half-life
GB8400653D0 (en) * 1984-01-11 1984-02-15 Beecham Group Plc Conjugates
DE3663030D1 (en) * 1985-02-07 1989-06-01 Kowa Co Monoclonal antibodies to tissue plasminogen activator derived from human normal cells
JPS61183299A (ja) * 1985-02-08 1986-08-15 Kowa Co 人正常細胞由来の組織型プラスミノ−ゲンアクチベ−タ−に対する新規なモノクロナル抗体およびそれによる精製法ならびに検出法
JPS61221128A (ja) * 1985-03-26 1986-10-01 Snow Brand Milk Prod Co Ltd プラスミノ−ゲン活性化因子に対するモノクロ−ナル抗体とその調製方法及び該モノクロ−ナル抗体の使用方法
EP0241907A3 (en) * 1986-04-14 1989-09-13 The General Hospital Corporation Heterobifunctional antibodies and method of use
US4891312A (en) * 1986-08-13 1990-01-02 Monsanto Company Monoclonal antibody specific for human colon fibroblast-derived t-PA
US4833085A (en) * 1986-08-13 1989-05-23 Monsanto Company Monoclonal antibody specific for human colon fibroblast-derived t-PA
US5009888A (en) * 1987-04-13 1991-04-23 Genzyme Corporation Therapeutic enzyme-antibody complexes

Also Published As

Publication number Publication date
FI891956L (fi) 1989-10-27
NO891713D0 (no) 1989-04-25
EP0339505A2 (en) 1989-11-02
AU3332389A (en) 1989-11-02
ZA893088B (en) 1990-12-28
US5225540A (en) 1993-07-06
DK166489A (da) 1989-10-27
DK166489D0 (da) 1989-04-06
FI891956A7 (fi) 1989-10-27
EP0339505A3 (en) 1990-05-16
PT90364A (pt) 1989-11-10
JPH0213395A (ja) 1990-01-17
IL90054A0 (en) 1989-12-15
FI891956A0 (fi) 1989-04-25
KR900015759A (ko) 1990-11-10

Similar Documents

Publication Publication Date Title
Collen et al. Tissue-type plasminogen activator: a review of its pharmacology and therapeutic use as a thrombolytic agent
EP3013366B1 (en) Combination therapy using a factor xii inhibitor and a c1-inhibitor
CN108289851B (zh) 长效凝固因子及其产生方法
CN103429256B (zh) 凝血因子向活化的血小板上的tlt-1的靶向
US6280730B1 (en) Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
US4996050A (en) Fibrinolytic activity enhancer
Lenich et al. Assembly and activation of the intrinsic fibrinolytic pathway on the surface of human endothelial cells in culture
US6416963B1 (en) Cleaved fragments of fibrinogen
NO891713L (no) Monoklonale antistoffer til vevplasminogenaktivator (t-pa)
CN106890320A (zh) 一种用于预防或治疗急性及慢性血栓的方法
US5811265A (en) Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use
Dewerchin et al. Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase
US5620688A (en) Methods of inhibiting the activation of Factor XIII
WO2004041296A2 (en) Pharmaceutical composition comprising a tissue factor antagonist and protein c polypeptides
Kurokawa et al. Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activator
WO1989009817A1 (en) Composition and method for acceleration of clot lysis
Hanaoka et al. A novel and potent thrombolytic fusion protein consisting of anti-insoluble fibrin antibody and mutated urokinase
US20040198660A1 (en) Tissue factor antagonist and protein C polypeptide compositions
US5609869A (en) Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use
EP4506458A1 (en) Antibody binding to fibrin, fibrinolytic protein containing antibody, and pharmaceutical formulation containing protein
Wan et al. A recombinant antibody-targeted plasminogen activator with high affinity for activated platelets increases thrombolytic potency in vitro and in vivo
Lijnen et al. The key to fibrinolysis and thrombolysis
CN118922548A (zh) 与纤维蛋白结合的抗体、含有该抗体的纤维蛋白溶解性蛋白质和含有该蛋白质的药物制剂
JP2904893B2 (ja) 医薬製剤
Rosenfeld et al. Heparin enhances active site-dependent binding of tissue-type plasminogen activator to endothelial cells